Agricultural Biotechnology: Seeds of Promise in Pharma

Cover Articles
August 2, 2022
by Cindy H. Dubin, Contributor

In February 2022, biotech company Medicago gained approval in Canada for its two-dose COVID-19 vaccine Covifenz. Phase III results showed that the vaccine has similar efficacy rates to other  COVID-19 vaccines, but with one glaring difference: it is the world’s first plant-based COVID-19 vaccine.